134 related articles for article (PubMed ID: 2388339)
1. Adrenal adenoma with excess secretion of corticosterone and 18-hydroxycorticosterone.
Morioka M; Sen Y; Inoue K; Fujita Y
J Urol; 1990 Sep; 144(3):731-2. PubMed ID: 2388339
[TBL] [Abstract][Full Text] [Related]
2. Increased excretion of 18-hydroxycorticosterone in patients with adrenal adenomas and hypertension.
Vecsei P; Abdelhamid S; Haack D; Lichtwald K; Lewicka S; von Mittelstädt G
Clin Exp Hypertens A; 1982; 4(9-10):1759-70. PubMed ID: 6291815
[TBL] [Abstract][Full Text] [Related]
3. Altered responses of plasma 18-hydroxycorticosterone and aldosterone to angiotensin II and adrenocorticotropin in patients with a 18-hydroxycorticosterone-producing tumor.
Uchida K; Kigoshi T; Iwasaki R; Morimoto S
Jpn J Med; 1989; 28(4):446-51. PubMed ID: 2554039
[TBL] [Abstract][Full Text] [Related]
4. Effects of corticotropin-releasing factor (CRF) on aldosterone and 18-hydroxycorticosterone secretion.
Maser-Gluth C; Toygar A; Schaz K; Vecsei P
Clin Exp Hypertens A; 1984; 6(10-11):2097-100. PubMed ID: 6099779
[TBL] [Abstract][Full Text] [Related]
5. The constant plasma 18-hydroxycorticosterone to aldosterone ratio: an expression of the efficacy of corticosterone methyloxidase type II activity in disorders with variable aldosterone production.
Kater CE; Biglieri EG; Rost CR; Schambelan M; Hirai J; Chang BC; Brust N
J Clin Endocrinol Metab; 1985 Feb; 60(2):225-8. PubMed ID: 2981240
[TBL] [Abstract][Full Text] [Related]
6. Adrenal adenoma with 18-hydroxycorticosterone excess and hypertension: a variant of aldosteronomas.
Kigoshi T; Imaizumi N; Azukizawa S; Yamamoto I; Hosojima H; Uchida K; Morimoto S
Horm Res; 1984; 19(4):224-31. PubMed ID: 6745843
[TBL] [Abstract][Full Text] [Related]
7. Hypermineralocorticoidism due to adrenal carcinoma: plasma corticosteroids and their response to ACTH and angiotensin II.
Isles CG; MacDougall IC; Lever AF; Fraser R
Clin Endocrinol (Oxf); 1987 Feb; 26(2):239-51. PubMed ID: 2822295
[TBL] [Abstract][Full Text] [Related]
8. Adrenocortical adenoma producing 18-hydroxycorticosterone.
Un-no T; Kageyama S; Ushiyama T; Suzuki K; Fujita K
Int J Urol; 1996 Nov; 3(6):491-3. PubMed ID: 9170579
[TBL] [Abstract][Full Text] [Related]
9. 18-hydroxycorticosterone: a review.
Fraser R; Lantos CP
J Steroid Biochem; 1978 Mar; 9(3):273-86. PubMed ID: 25994
[No Abstract] [Full Text] [Related]
10. Concurrent hypercortisolism and hyperaldosteronism due to an adrenal adenoma.
Hobma S; Hermus A; Pieters G; Smals A; Kloppenborg P
Klin Wochenschr; 1990 Oct; 68(19):981-3. PubMed ID: 2232630
[TBL] [Abstract][Full Text] [Related]
11. Zona fasciculata origin of 18-hydroxycorticosterone in the chronically suppressed zona glomerulosa.
Kater CE; Biglieri EG
J Clin Endocrinol Metab; 1982 Oct; 55(4):628-33. PubMed ID: 7107809
[No Abstract] [Full Text] [Related]
12. An antioxidant drug, silibinin, modulates steroid secretion in human pathological adrenocortical cells.
Rácz K; Fehér J; Csomós G; Varga I; Kiss R; Gláz E
J Endocrinol; 1990 Feb; 124(2):341-5. PubMed ID: 2155989
[TBL] [Abstract][Full Text] [Related]
13. Comparative biosynthetic studies in a case of primary aldosteronism.
Dahl V; Scattini CM; Lantos CP
J Steroid Biochem; 1976 Sep; 7(9):715-7. PubMed ID: 185466
[No Abstract] [Full Text] [Related]
14. Oxygenation of 18-hydroxycorticosterone as the final reaction for aldosterone biosynthesis.
Kojima I; Ogata E; Inano H; Tamaoki B
Acta Endocrinol (Copenh); 1984 Nov; 107(3):395-400. PubMed ID: 6507007
[TBL] [Abstract][Full Text] [Related]
15. The conversion of 18-hydroxycorticosterone and 18-hydroxy-11-deoxycorticosterone to aldosterone by rat adrenal tissue: evidence for an alternative biosynthetic pathway.
Müller J
J Steroid Biochem; 1980 Mar; 13(3):245-51. PubMed ID: 7392603
[No Abstract] [Full Text] [Related]
16. Enzyme immunoassay for serum 18-hydroxycorticosterone and its clinical application.
Watanabe F; Ryota T; Kobayashi Y
Steroids; 1984 May; 43(5):509-16. PubMed ID: 6397877
[TBL] [Abstract][Full Text] [Related]
17. [Tetraparesis revealing Conn adenoma in a pregnant woman].
Assoufi N; Bahadi N; Omri NE; Sekkach Y; Ameziane T; Ghafir D
Pan Afr Med J; 2016; 25():24. PubMed ID: 28154716
[TBL] [Abstract][Full Text] [Related]
18. The prediction of anatomical morphology of primary aldosteronism using serum 18-hydroxycorticosterone levels.
Kem DC; Tang K; Hanson CS; Brown RD; Painton R; Weinberger MH; Hollifield JW
J Clin Endocrinol Metab; 1985 Jan; 60(1):67-73. PubMed ID: 3964794
[TBL] [Abstract][Full Text] [Related]
19. [In vivo and in vitro studies on 18-hydroxy-11-deoxycorticosterone and 18-hydroxycorticosterone in normal subjects and in those with various adrenocortical disorders (author's transl)].
Ojima M; Kambegawa A
Nihon Naibunpi Gakkai Zasshi; 1979 Aug; 55(8):994-1006. PubMed ID: 226427
[TBL] [Abstract][Full Text] [Related]
20. Evidence for direct inhibitory effects of dopamine on zona glomerulosa secretion of 18-hydroxycorticosterone in rhesus monkeys.
Sowers JR; Beck FW; Eggena P
Life Sci; 1984 Jun; 34(24):2339-46. PubMed ID: 6727568
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
